i
Interim clinical considerations for Moderna and Janssen COVID-19 vaccine booster doses
-
October 21, 2021
By Reddy, SujanSeries: ACIP meeting COVID-19 Vaccines
Details:
-
Personal Author:
-
Conference Authors:
-
Subject:
-
Series:
-
Document Type:
-
Name as Subject:
-
Genre:
-
Collection(s):
-
Main Document Checksum:urn:sha256:7630afe5b5c04f75d55fd304869829a353e9b291fa12c2c3124306fb7a9163ac
-
File Type:
Supporting Files
-
No Additional Files
More +
Related Documents
-
- File Format:
- RIS
- File Format:
- RIS
Evidence to recommendation framework : Moderna & Janssen COVID-19 vaccine booster doseCiteBooster dose of Janssen COVID-19 Vaccine (Ad26.COV2.S) following primary vaccinationCite
More +
You May Also Like
Checkout today's featured content at stacks.cdc.gov